Drug Profile
Davasaicin
Alternative Names: capsavanil; DA 5018; KR 25018Latest Information Update: 08 Nov 2002
Price :
$50
*
At a glance
- Originator Korea Research Institute of Chemical Technology
- Developer Dong-A Pharmaceutical
- Class Non-opioid analgesics
- Mechanism of Action TRPV cation channel agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Diabetic neuropathies; Neuralgia; Pain; Pruritus